Healthcare provider profile · identity verified

Kaya J Oyejide, MD

Family Practice · PHILADELPHIA, PA · NPI 1356541585

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1117	256
Amlodipine Besylate	Amlodipine Besylate	799	213
Albuterol Sulfate Hfa	Albuterol Sulfate	527	120
Gabapentin	Gabapentin	391	100
Metoprolol Succinate	Metoprolol Succinate	368	84
Metformin Hcl	Metformin Hcl	320	75
Lisinopril	Lisinopril	315	85
Fluticasone Propionate	Fluticasone Propionate	314	80
Losartan Potassium	Losartan Potassium	290	75
Rosuvastatin Calcium	Rosuvastatin Calcium	290	71
Carvedilol	Carvedilol	247	59
Furosemide	Furosemide	241	49
Eliquis	Apixaban	225	41
Omeprazole	Omeprazole	211	46
Montelukast Sodium	Montelukast Sodium	189	41
Hydrochlorothiazide	Hydrochlorothiazide	183	49
Tamsulosin Hcl	Tamsulosin Hcl	177	46
Diclofenac Sodium	Diclofenac Sodium	168	53
Levothyroxine Sodium	Levothyroxine Sodium	159	34
Chlorthalidone	Chlorthalidone	153	40
Allopurinol	Allopurinol	151	38
Nifedipine Er	Nifedipine	151	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	141	36
Ozempic	Semaglutide	141	31
Famotidine	Famotidine	140	31
Hydralazine Hcl	Hydralazine Hcl	130	26
Pantoprazole Sodium	Pantoprazole Sodium	130	33
Duloxetine Hcl	Duloxetine Hcl	129	34
Sertraline Hcl	Sertraline Hcl	125	29
Farxiga	Dapagliflozin Propanediol	122	24
Trulicity	Dulaglutide	120	24
Spironolactone	Spironolactone	110	29
Valsartan	Valsartan	100	28
Breo Ellipta	Fluticasone/Vilanterol	95	16
Metformin Hcl Er	Metformin Hcl	92	26
Clopidogrel	Clopidogrel Bisulfate	90	21
Trazodone Hcl	Trazodone Hcl	89	31
Pregabalin	Pregabalin	85	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	85	23
Jardiance	Empagliflozin	81	23
Tramadol Hcl	Tramadol Hcl	76	21
Entresto	Sacubitril/Valsartan	74	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	73	13
Ibuprofen	Ibuprofen	70	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	70	15
Escitalopram Oxalate	Escitalopram Oxalate	67	14
Triamcinolone Acetonide	Triamcinolone Acetonide	62	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	22
Ezetimibe	Ezetimibe	57	14
Potassium Chloride	Potassium Chloride	56	16
Donepezil Hcl	Donepezil Hcl	55	11
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	54	23
Levetiracetam	Levetiracetam	51	13
Pravastatin Sodium	Pravastatin Sodium	51	14
Meloxicam	Meloxicam	49	16
Tizanidine Hcl	Tizanidine Hcl	46	15
Bumetanide	Bumetanide	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	suppressed
Azithromycin	Azithromycin	43	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Mounjaro	Tirzepatide	43	suppressed
Lidocaine	Lidocaine	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	12
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	36	suppressed
Baclofen	Baclofen	36	11
Memantine Hcl	Memantine Hcl	36	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Doxepin Hcl	Doxepin Hcl	34	suppressed
Glipizide Er	Glipizide	34	suppressed
Naproxen	Naproxen	33	19
Novolog Flexpen	Insulin Aspart	32	suppressed
Tresiba Flextouch U-200	Insulin Degludec	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	suppressed
Prednisone	Prednisone	29	21
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Hydrocortisone	Hydrocortisone	26	13
Januvia	Sitagliptin Phosphate	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Colchicine	Colchicine	25	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Linzess	Linaclotide	21	suppressed
Nystatin	Nystatin	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Risperidone	Risperidone	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cilostazol	Cilostazol	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Desloratadine	Desloratadine	18	suppressed
Glipizide	Glipizide	18	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Atenolol	Atenolol	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ketoconazole	Ketoconazole	17	15
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Clonidine	Clonidine	16	suppressed
Finasteride	Finasteride	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Topiramate	Topiramate	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Torsemide	Torsemide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Zafirlukast	Zafirlukast	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Simvastatin	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error